Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Anne Valente MD
Anne Marie Valente MD Advisory Board
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
See All Experts
story of the week
Published in Cardiology and
3 other channels

Journal Scan / Research · October 29, 2021

Association of Rivaroxaban With Higher Rates of GI Bleeding

Annals of Internal Medicine

 

 Save  Recommend
 Share

Additional Info

Annals of Internal Medicine
Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants: A Nationwide Propensity Score-Weighted Study
Ann. Intern. Med 2021 Oct 12;[EPub Ahead of Print], AB Ingason, JP Hreinsson, AS Ágústsson, SH Lund, E Rumba, DA Pálsson, IE Reynisson, BR Guðmundsdóttir, PT Önundarson, ES Björnsson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated